EGFR tyrosine kinase inhibitor - Globe Thesis

Keyword [EGFR tyrosine kinase inhibitor] Result: 1 - 20 \| Page: 1 of 1
1.	Expression And Synthesis Of 5 - Pyrimidino [5,4-b] Indole Derivatives Of EGFR Tyrosine Kinase Inhibitors
2.	Synthesis And Optimization Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Gefitinib
3.	Antiproliferative Effects Of EGFR Tyrosine Kinase Inhibitor AG1478 On Human Renal Carcinoma Cell Line GRC-1
4.	Four Yuan Heterocyclic Small Molecule Modification, Synthesis And The Treatment Of Egfr Tyrosine Kinase Inhibitor Modification Research
5.	Mechanism Of EGFR Tyrosine Kinase Inhibitor-induced Injury In Intestinal Epithelialium
6.	Constrution Of FOXQ1-silenced Colorectal Cancer Cell And The Research Of Relationship Between FOXQ1 And EGFR Gene
7.	Efficacy And Safety Of EGFR Tyrosine Kinase Inhibitor Monotherapy With Docetaxel Monotherapy In Previously Treated Advanced Non-Small-Cell Lung Cancer: A Meta-analysis
8.	Anti-tumor Activity Of High-dose EGFR Tyrosine Kinase Inhibitor Combined With Docetaxel Against Lung Cancer With EGFR Wild Type In Vivo
9.	Icotinib Alone Or With Radio Therapy In Patients With EGFR Mutations Non-small Cell Lung Cancer Who Develop Brain Metastases
10.	The Impact Of Epidermal Growth Factor Receptor Mutation On The Treatment Strategy And Outcomes Of Patients With Non-small Cell Lung Cancer
11.	Tumor Microenvironment-related Factors On NSCLC Resistance To EGFR-tyrosine Kinase Inhibitor Gefitinib And The Underlying Mechanism
12.	The Role And Mechanism Of HSP70 In The Acquired Resistance Of EGFR-TKI-sensitive Non-small Cell Lung Cancer
13.	The Relationship Between Rare EGFR Mutation And Clinicopathological Features Of Non-small Cell Lung Cancer
14.	The Research Of Inhibitory Effect Of EGFR Tyrosine Kinase Inhibitor On Lung Cancer Cells
15.	Three New Disease-progression Modes In NSCLC Patients After EGFR-TKIs Treatment By Next-Generation Sequencing Analysis
16.	Study Of A Novel EGFR Tyrosine Kinase Inhibitor In The Treatment Of Prostate Cancer
17.	Correlation On Mutation Of EGFR And Treatment Effect Of EGFR Tyrosine Kinase Inhibitor With Serum Level Of Tumor Marker In Lung Adenocarcinoma
18.	Selective COX-2 Inhibitor Combined With EGFR-tyrosine Kinase Inhibitor Study On The Growth And Apoptosis Of Non-small Cell Lung Cancer And Its Mechanisms
19.	Systematic Study Of The Role And Molecular Mechanism Of B7 Family Proteins In Gastric Cancer
20.	Experimental Study Of Aumolertinib Crossing The Blood-brain Barrier In EGFR-Mutant NSCLC Brain Transplant Tumor And Spinal Cord Metastasis Tumor Models
<<First <Prev Next> Last>> Jump to